| Application no. and date | 18852857.4 (espacenet) (Federated) (European Patent Register), 20180907 | | Patent/reg. no. and date | DK/EP 3679046, 20231108 | | Publication date | 20200715 | | Priority no. and date | US 201762555676 P, 20170908 | | EP pub. no. and date |
EP 3679046 20200715 | | Effective date | | | Applicant/owner | Promontory Therapeutics Inc., 1350 Ave. of the Americas, 23rd Fl.
New York, NY 10019, US | | Applicant ref. no. | | | Inventor | AMES, Tyler,
New York, NY 10019, US,
PRICE, Matthew,
New York, NY 10019, US | | Representative | | | Opponent | | | IPC Class | A61K 31/675 (2006.01) , A61K 33/24 (2019.01) , A61K 39/00 (2006.01) , A61K 39/39 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07F 15/00 (2006.01) | | Title | PHOSPHAPLATIN COMPOUNDS AS IMMUNO-MODULATORY AGENTS AND THERAPEUTIC USES THEREOF | | Int. application no. | US2018049980 | | Int. publication no. | WO2019051246 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
